First Time Loading...

Exicure Inc
NASDAQ:XCUR

Watchlist Manager
Exicure Inc Logo
Exicure Inc
NASDAQ:XCUR
Watchlist
Price: 0.515 USD -4.68% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

XCUR doesn't have a meaningful market cap.
XCUR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. [ Read More ]

The intrinsic value of one XCUR stock under the Base Case scenario is 2.907 USD. Compared to the current market price of 0.515 USD, Exicure Inc is Undervalued by 82%.

Key Points:
XCUR Intrinsic Value
Base Case
2.907 USD
Undervaluation 82%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Exicure Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling XCUR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Exicure Inc

Provide an overview of the primary business activities
of Exicure Inc.

What unique competitive advantages
does Exicure Inc hold over its rivals?

What risks and challenges
does Exicure Inc face in the near future?

Has there been any significant insider trading activity
in Exicure Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Exicure Inc.

Provide P/S
for Exicure Inc.

Provide P/E
for Exicure Inc.

Provide P/OCF
for Exicure Inc.

Provide P/FCFE
for Exicure Inc.

Provide P/B
for Exicure Inc.

Provide EV/S
for Exicure Inc.

Provide EV/GP
for Exicure Inc.

Provide EV/EBITDA
for Exicure Inc.

Provide EV/EBIT
for Exicure Inc.

Provide EV/OCF
for Exicure Inc.

Provide EV/FCFF
for Exicure Inc.

Provide EV/IC
for Exicure Inc.

Show me price targets
for Exicure Inc made by professional analysts.

What are the Revenue projections
for Exicure Inc?

How accurate were the past Revenue estimates
for Exicure Inc?

What are the Net Income projections
for Exicure Inc?

How accurate were the past Net Income estimates
for Exicure Inc?

What are the EPS projections
for Exicure Inc?

How accurate were the past EPS estimates
for Exicure Inc?

What are the EBIT projections
for Exicure Inc?

How accurate were the past EBIT estimates
for Exicure Inc?

Compare the revenue forecasts
for Exicure Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Exicure Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Exicure Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Exicure Inc compared to its peers.

Compare the P/E ratios
of Exicure Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Exicure Inc with its peers.

Analyze the financial leverage
of Exicure Inc compared to its main competitors.

Show all profitability ratios
for Exicure Inc.

Provide ROE
for Exicure Inc.

Provide ROA
for Exicure Inc.

Provide ROIC
for Exicure Inc.

Provide ROCE
for Exicure Inc.

Provide Gross Margin
for Exicure Inc.

Provide Operating Margin
for Exicure Inc.

Provide Net Margin
for Exicure Inc.

Provide FCF Margin
for Exicure Inc.

Show all solvency ratios
for Exicure Inc.

Provide D/E Ratio
for Exicure Inc.

Provide D/A Ratio
for Exicure Inc.

Provide Interest Coverage Ratio
for Exicure Inc.

Provide Altman Z-Score Ratio
for Exicure Inc.

Provide Quick Ratio
for Exicure Inc.

Provide Current Ratio
for Exicure Inc.

Provide Cash Ratio
for Exicure Inc.

What is the historical Revenue growth
over the last 5 years for Exicure Inc?

What is the historical Net Income growth
over the last 5 years for Exicure Inc?

What is the current Free Cash Flow
of Exicure Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Exicure Inc.

Financials

Balance Sheet Decomposition
Exicure Inc

Current Assets 3.7m
Cash & Short-Term Investments 2.3m
Other Current Assets 1.4m
Non-Current Assets 13.9m
Long-Term Investments 2m
PP&E 8.7m
Other Non-Current Assets 3.2m
Current Liabilities 1.4m
Accounts Payable 300k
Accrued Liabilities 1.1m
Non-Current Liabilities 6.5m
Other Non-Current Liabilities 6.5m
Efficiency

Earnings Waterfall
Exicure Inc

Revenue
23.8m USD
Operating Expenses
-20.6m USD
Operating Income
3.2m USD
Other Expenses
-130k USD
Net Income
3.1m USD

Free Cash Flow Analysis
Exicure Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

XCUR Profitability Score
Profitability Due Diligence

Exicure Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Negative Free Cash Flow
Positive Operating Income
Positive Net Income
Exceptional ROE
58/100
Profitability
Score

Exicure Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

XCUR Solvency Score
Solvency Due Diligence

Exicure Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
53/100
Solvency
Score

Exicure Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XCUR Price Targets Summary
Exicure Inc

Wall Street analysts forecast XCUR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XCUR is 2 USD .

Lowest
Price Target
Not Available
Average
Price Target
2 USD
288% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

XCUR Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

XCUR Price
Exicure Inc

1M 1M
-18%
6M 6M
-18%
1Y 1Y
-44%
3Y 3Y
-99%
5Y 5Y
-99%
10Y 10Y
-99%
Annual Price Range
0.515
52w Low
0.37
52w High
1.44
Price Metrics
Average Annual Return -51.36%
Standard Deviation of Annual Returns 39.64%
Max Drawdown -100%
Shares Statistics
Market Capitalization 4.4m USD
Shares Outstanding 8 648 310
Percentage of Shares Shorted 2.39%

XCUR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Exicure Inc Logo
Exicure Inc

Country

United States of America

Industry

Biotechnology

Market Cap

4.4m USD

Dividend Yield

0%

Description

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The company is headquartered in Chicago, Illinois and currently employs 47 full-time employees. The company went IPO on 2018-05-09. The firm is engaged in developing therapeutics for neurology, immuno-oncology, inflammatory diseases and other genetic disorders based on its spherical nucleic acid (SNA) technology. The firm develops XCUR-FXN, which is a spherical nucleic acid (SNA) -based therapeutic candidate for the treatment of Friedreich’s ataxia (FA). XCUR-FXN through its SNA technology incorporates more than one active oligonucleotides in a single SNA molecule. The Company’s therapeutic candidate cavrotolimod (AST-008) is a toll-like receptor 9 (TLR9) agonist designed for immuno-oncology applications utilizing its SNA technology. AST-008 is in a Phase I b/II clinical trial in patients with advanced solid tumors. TLR9 agonists binds to and activate TLR9.

Contact

ILLINOIS
Chicago
2430 N. Halsted St.
+18476731700.0
http://www.exicuretx.com/

IPO

2018-05-09

Employees

47

Officers

CEO & Director
Mr. Paul Kang
CFO & Director
Ms. Jiyoung Hwang
Chief Accounting Officer
Mr. Joshua Miller
Senior Director of R&D
Mr. Bart Anderson

See Also

Discover More
What is the Intrinsic Value of one XCUR stock?

The intrinsic value of one XCUR stock under the Base Case scenario is 2.907 USD.

Is XCUR stock undervalued or overvalued?

Compared to the current market price of 0.515 USD, Exicure Inc is Undervalued by 82%.